This study aimed to investigate the psychometric properties of the Fatigue Severity Scale (FSS), a widely used unidimensional fatigue measure, in patients with major depression.
Subjects included were 72 patients with major depressive disorder, diagnosed with the DSM-IV based M.I.N.I. 5.0.0., without comorbid fatigue-associated conditions and Hamilton Depression Rating Scale (HDRS) scores ≥ 17 as well as 40 sex- and age-matched healthy controls. The FSS was administered to patients on two time points separated by a 1-week interval and to controls. The vitality subscale of the 36-item Short Form Health Survey (SF-36vit) and a visual analogue fatigue scale (VASF) were also administered.
A total of 79.2% of patients vs. 15% of controls were fatigue cases according to the M.I.N.I. fatigue/energy loss item. The distribution of FSS scores was negatively skewed in the patient group, demonstrating a ceiling effect. The FSS presented satisfactory test–retest reliability (intraclass correlation coefficient 0.993), internal consistency (Cronbach’s α coefficient 0.947), concurrent validity (correlations with SF-36vit, VASF and HDRS were −0.52, 0.73 and 0.32, respectively) and discriminative validity between patients and controls. Factor analysis demonstrated a unidimensional structure. The optimal FSS cutoff score for clinically significant fatigue was 5.4 against the presence of fatigue/energy loss according to the M.I.N.I. as a ‘gold standard’.
When administered to patients with major depression, the FSS was shown to have satisfactory psychometric properties with the exception of a ceiling effect, which may pose limitations to its use in this population.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Pawlikowska, T., Chalder, T., Hirsch, S. R., et al. (1994). Population based study of fatigue and psychological distress. British Medical Journal, 308, 763–766.
David, A., Pelosi, A., McDonald, E., et al. (1990). Tired, weak, or in need of rest: Fatigue among general practice attenders. British Medical Journal, 301, 1199–1202.
Maurice-Tison, S., Verdoux, H., Gay, B., et al. (1998). How to improve recognition and diagnosis of depressive syndromes using international diagnostic criteria. British Journal of General Practice, 48, 1245–1246.
Tylee, A., Gastpar, M., Lepine, J. P., & Mendlewicz, J. (1999). DEPRES II (Depression Research in European Society II): A patient survey of the symptoms, disability and current management of depression in the community. International Clinical Psychopharmacology, 14, 139–151.
Demyttenaere, K., De Fruyt, J., & Stahl, S. M. (2005). The many faces of fatigue in major depressive disorder. International Journal of Neuropsychopharmacology, 8, 93–105.
Stahl, S. M., Zhang, L., Damatarca, C., & Grady, M. (2003). Brain circuits determine destiny in depression: A novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. Journal of Clinical Psychiatry, 64(Suppl 14), 6–17.
Paykel, E. S., Ramana, R., Cooper, Z., et al. (1995). Residual symptoms after partial remission: An important outcome in depression. Psychological Medicine, 25, 1171–1180.
Dittner, A. J., Wessely, S. C., & Brown, R. G. (2004). The assessment of fatigue: A practical guide for clinicians and researchers. Journal of Psychosomatic Research, 56, 157–170.
Ferentinos, P. P., Kontaxakis, V. P., Havaki-Kontaxaki, B. J., Paplos, K. G., & Soldatos, C. R. (2007). The measurement of fatigue in depression. Psychopathology, 40, 133–134.
Ferentinos, P., Kontaxakis, V., Havaki-Kontaxaki, B., Dikeos, D., & Papadimitriou, G. (2010). The Fatigue Questionnaire: Standardization in patients with major depression. Psychiatry Research, 177, 114–119.
Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Steinberg, A. D. (1989). The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology, 46, 1121–1123.
Kleinman, L., Zodet, M. W., Hakim, Z., et al. (2000). Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Quality of Life Research, 9, 499–508.
Mattsson, M., Moller, B., Lundberg, I., Gard, G., & Bostrom, C. (2008). Reliability and validity of the Fatigue Severity Scale in Swedish for patients with systemic lupus erythematosus. Scandinavian Journal of Rheumatology, 37, 269–277.
Merkies, I. S., Schmitz, P. I., Samijn, J. P., van der Meche, F. G., & van Doorn, P. A. (1999). Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology, 53, 1648–1654.
Abe, K., Takanashi, M., & Yanagihara, T. (2000). Fatigue in patients with Parkinson’s disease. Behavioural Neurology, 12, 103–106.
Friedberg, F., & Krupp, L. B. (1994). A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression. Clinical Infectious Diseases, 18, S105–S110.
LaChapelle, D. L., & Finlayson, M. A. (1998). An evaluation of subjective and objective measures of fatigue in patients with brain injury and healthy controls. Brain Injury, 12, 649–659.
Lichstein, K. L., Means, M. K., Noe, S. L., & Aguillard, R. N. (1997). Fatigue and sleep disorders. Behaviour Research and Therapy, 35, 733–740.
Stone, P., Richards, M., A’Hern, R., & Hardy, J. (2000). A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Annals of Oncology, 11, 561–567.
Pepper, C. M., Krupp, L. B., Friedberg, F., Doscher, C., & Coyle, P. K. (1993). A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. Journal of Neuropsychiatry and Clinical Neurosciences, 5, 200–205.
DeBattista, C., Doghramji, K., Menza, M. A., Rosenthal, M. H., & Fieve, R. R. (2003). Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: A preliminary double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 64, 1057–1064.
Ninan, P. T., Hassman, H. A., Glass, S. J., & McManus, F. C. (2004). Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue. Journal of Clinical Psychiatry, 65, 414–420.
Schwartz, T. L., Azhar, N., Cole, K., et al. (2004). An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy. Journal of Clinical Psychiatry, 65, 1223–1227.
Lundt, L. (2004). Modafinil treatment in patients with seasonal affective disorder/winter depression: An open-label pilot study. Journal of Affective Disorders, 81, 173–178.
Fava, M., Thase, M. E., & DeBattista, C. (2005). A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. Journal of Clinical Psychiatry, 66, 85–93.
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., et al. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl 20), 22–33.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.
Fava, G. A., Kellner, R., Munari, F., & Pavan, L. (1982). The Hamilton depression rating scale in normals and depressives. Acta Psychiatrica Scandinavica, 66, 26–32.
Sartorius, N., & Janca, A. (1996). Psychiatric assessment instruments developed by the world health organization. In G. Thornicroft & M. Tansella (Eds.), Mental health outcome measures (pp. 153–177). Berlin: Springer.
Ware, J. E., Snow, K. K., Kosinki, M., & Gandek, B. (1993). SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute.
Shrout, P. E., & Fleiss, J. L. (1979). Intraclass correlations: Uses in assessing rater reliability. Psychological Bulletin, 86, 420–428.
McGraw, K. O., & Wong, S. P. (1996). Forming inferences about some intraclass correlation coefficients. Psychological Methods, 1, 30–46.
Altman, D. G. (1996). Inter-rater agreement in practical statistics for medical research. London, UK: Chapman & Hall.
Anderson, K. O., Getto, C. J., Mendoza, T. R., et al. (2003). Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. Journal of Pain and Symptom Management, 25, 307–318.
Lerdal, A., Wahl, A., Rustoen, T., Hanestad, B. R., & Moum, T. (2005). Fatigue in the general population: A translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scandinavian Journal of Public Health, 33, 123–130.
Loge, J. H., Ekeberg, O., & Kaasa, S. (1998). Fatigue in the general Norwegian population: Normative data and associations. Journal of Psychosomatic Research, 45, 53–65.
Kroenke, K., & Price, R. K. (1993). Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Archives of Internal Medicine, 153, 2474–2480.
van Nes, S. I., Vanhoutte, E. K., Faber, C. G., et al. (2009). Improving fatigue assessment in immune-mediated neuropathies: The modified Rasch-built fatigue severity scale. Journal of the Peripheral Nervous System, 14, 268–278.
Mills, R., Young, C., Nicholas, R., Pallant, J., & Tennant, A. (2009). Rasch analysis of the Fatigue Severity Scale in multiple sclerosis. Multiple Sclerosis, 15, 81–87.
Lerdal, A., Johansson, S., Kottorp, A., & von Koch, L. (2010). Psychometric properties of the Fatigue Severity Scale: Rasch analyses of responses in a Norwegian and a Swedish MS cohort. Multiple Sclerosis, 16, 733–741.
Winstead-Fry, P. (1998). Psychometric assessment of four fatigue scales with a sample of rural cancer patients. Journal of Nursing Measurement, 6, 111–122.
MacCallum, R. C., Widaman, K. F., Zhang, S., & Hong, S. (1999). Sample size in factor analysis. Psychological Methods, 4, 84–99.
Bryant, F. B., & Yarnold, P. R. (1995). Principal components analysis and exploratory and confirmatory factor analysis. In L. G. Grimm & R. R. Yarnold (Eds.), Reading and understanding multivariale statistics (pp. 99–136). Washington, DC: American Psychological Association.
Roelcke, U., Kappos, L., Lechner-Scott, J., et al. (1997). Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F-fluorodeoxyglucose positron emission tomography study. Neurology, 48, 1566–1571.
Bakshi, R., Miletich, R. S., Henschel, K., et al. (1999). Fatigue in multiple sclerosis: Cross-sectional correlation with brain MRI findings in 71 patients. Neurology, 53, 1151–1153.
Lerdal, A., Celius, E. G., Krupp, L., & Dahl, A. A. (2007). A prospective study of patterns of fatigue in multiple sclerosis. European Journal of Neurology, 14, 1338–1343.
Ferentinos, P., Kontaxakis, V., Havaki-Kontaxaki, B., et al. (2009). Sleep disturbances in relation to fatigue in major depression. Journal of Psychosomatic Research, 66, 37–42.
Fuhrer, R., & Wessely, S. (1995). The epidemiology of fatigue and depression: A French primary-care study. Psychological Medicine, 25, 895–905.
Papakostas, G. I. (2008). Tolerability of modern antidepressants. Journal of Clinical Psychiatry, 69(Suppl E1), 8–13.
Rights and permissions
About this article
Cite this article
Ferentinos, P., Kontaxakis, V., Havaki-Kontaxaki, B. et al. Psychometric evaluation of the Fatigue Severity Scale in patients with major depression. Qual Life Res 20, 457–465 (2011). https://doi.org/10.1007/s11136-010-9769-3
- Cutoff score
- Fatigue Severity Scale
- Major depression